Optimizing Treatment for Children in the Developing World (eBook, PDF)
Redaktion: Macleod, Stuart; Rane, Anders; Koren, Gideon; Hill, Suzanne
40,95 €
40,95 €
inkl. MwSt.
Sofort per Download lieferbar
20 °P sammeln
40,95 €
Als Download kaufen
40,95 €
inkl. MwSt.
Sofort per Download lieferbar
20 °P sammeln
Jetzt verschenken
Alle Infos zum eBook verschenken
40,95 €
inkl. MwSt.
Sofort per Download lieferbar
Alle Infos zum eBook verschenken
20 °P sammeln
Optimizing Treatment for Children in the Developing World (eBook, PDF)
Redaktion: Macleod, Stuart; Rane, Anders; Koren, Gideon; Hill, Suzanne
- Format: PDF
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
Bitte loggen Sie sich zunächst in Ihr Kundenkonto ein oder registrieren Sie sich bei
bücher.de, um das eBook-Abo tolino select nutzen zu können.
Hier können Sie sich einloggen
Hier können Sie sich einloggen
Sie sind bereits eingeloggt. Klicken Sie auf 2. tolino select Abo, um fortzufahren.
Bitte loggen Sie sich zunächst in Ihr Kundenkonto ein oder registrieren Sie sich bei bücher.de, um das eBook-Abo tolino select nutzen zu können.
This book is intended to communicate current best practice in pediatric clinical pharmacology and clinical pharmacy with special consideration of the prevailing circumstances and most pressing needs in developing countries. It also addresses measures that may be taken in countries with emerging economies through organizational and political adjustments to reduce unacceptable levels of morbidity and mortality among children and pregnant women with treatable diseases.
- Geräte: PC
- ohne Kopierschutz
- eBook Hilfe
- Größe: 5.93MB
Andere Kunden interessierten sich auch für
- Fundamentals of Pediatric Drug Dosing (eBook, PDF)105,95 €
- The MassGeneral Hospital for Children Adolescent Medicine Handbook (eBook, PDF)65,95 €
- Cough: Pathophysiology, Diagnosis and Treatment (eBook, PDF)73,95 €
- Clinical Manual of Fever in Children (eBook, PDF)113,95 €
- Optimizing IUD Delivery for Adolescents and Young Adults (eBook, PDF)44,95 €
- Systemic Corticosteroids for Inflammatory Disorders in Pediatrics (eBook, PDF)57,95 €
- Cong-Qiu ChuTargeting the IL-17 Pathway in Inflammatory Disorders (eBook, PDF)40,95 €
-
-
-
This book is intended to communicate current best practice in pediatric clinical pharmacology and clinical pharmacy with special consideration of the prevailing circumstances and most pressing needs in developing countries. It also addresses measures that may be taken in countries with emerging economies through organizational and political adjustments to reduce unacceptable levels of morbidity and mortality among children and pregnant women with treatable diseases.
Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.
Produktdetails
- Produktdetails
- Verlag: Springer International Publishing
- Seitenzahl: 332
- Erscheinungstermin: 12. Mai 2015
- Englisch
- ISBN-13: 9783319157504
- Artikelnr.: 43797972
- Verlag: Springer International Publishing
- Seitenzahl: 332
- Erscheinungstermin: 12. Mai 2015
- Englisch
- ISBN-13: 9783319157504
- Artikelnr.: 43797972
- Herstellerkennzeichnung Die Herstellerinformationen sind derzeit nicht verfügbar.
Since 2003, Dr Stuart MacLeod has been Professor of Pediatrics at the University of British Columbia in Vancouver, Canada. He was also Director of the Child & Family Research Institute at BC Children's Hospital until January 2010 and remains a senior clinician scientist at the Institute. Dr MacLeod received an MD from the University of Toronto in 1967 and completed postgraduate training in clinical pharmacology in 1973 at McGill University where he obtained a PhD in pharmacology in 1972. In the early stages of his career his research interests focused on biochemical pharmacology, drug hepatotoxicity and drug biotransformation. In 1979 Dr MacLeod became the founding leader of a Division of Pediatric Clinical Pharmacology at Toronto's Hospital for Sick Children. This University of Toronto unit has now thrived for 35 years and is the world's leading centre for training and research in pediatric pharmacology and toxicology. Dr MacLeod served as Dean of the Faculty of Health Sciences at McMaster University (1987-1992) and following the deanship founded the Centre for Evaluation of Medicines with a focus on therapeutics teaching, clinical pharmacology, population health sciences and pharmacoepidemiology. Since 1986, Dr MacLeod has held a major interest in international health with a focus on African maternal-child health. His current scientific interests embrace the multitude of factors that influence safe and effective drug treatments for children and the use of research findings to inform clinical and public policy.
Foreword. - Shifting demographics and regional disparities. - Access issues. - Ending stockouts. - Improved formulations and optimal dosing. - Deficient and counterfeit products. - Knowledge gaps in pregnancy and lactation. - Factors enabling improved therapy. - Regulatory science. - Human resource planning. - Information and communications technology. - Pharmaceutical care. - Networks (GRIP, INRUD, MSH, PTN,MYCRN, IABMC). - Research challenges. - Research standards for clinical trials in low and middle income countries. - Innovative appropriate trial methods. - Nutrition/micronutrients.- Impact on therapeutic outcomes. - Drug safety and pharmaco-epidemiology. - Personalized treatment and Pharmacogenomics. - Neglected diseases. - Health outcomes and economics. - Enhanced industry engagement. - Incorporating social science perspectives. - Clinical settings. - Treatment in the community. - Treatment at the district hospital level. - Care of the critically ill child. - Palliative care and pain management. - Conclusion. - The light at the end of the tunnel: future directions.
Foreword. - Shifting demographics and regional disparities. - Access issues. - Ending stockouts. - Improved formulations and optimal dosing. - Deficient and counterfeit products. - Knowledge gaps in pregnancy and lactation. - Factors enabling improved therapy. - Regulatory science. - Human resource planning. - Information and communications technology. - Pharmaceutical care. - Networks (GRIP, INRUD, MSH, PTN,MYCRN, IABMC). - Research challenges. - Research standards for clinical trials in low and middle income countries. - Innovative appropriate trial methods. - Nutrition/micronutrients.- Impact on therapeutic outcomes. - Drug safety and pharmaco-epidemiology. - Personalized treatment and Pharmacogenomics. - Neglected diseases. - Health outcomes and economics. - Enhanced industry engagement. - Incorporating social science perspectives. - Clinical settings. - Treatment in the community. - Treatment at the district hospital level. - Care of the critically ill child. - Palliative care and pain management. - Conclusion. - The light at the end of the tunnel: future directions.